Skip to main content
FBLG
NASDAQ Life Sciences

FibroBiologics' Fibroblast Technology Shows Promise in Burn Treatment, Targets $2.55B Market

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.35
Mkt Cap
$22.996M
52W Low
$0.22
52W High
$1.53
52W Position info
59% above low
Off High info
77% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

FBLG sits 59% above its 52-week low of $0.22.

Summary

FibroBiologics announced positive preclinical advances in burn treatment using its proprietary fibroblast spheroid technology, expanding its wound care platform into acute and chronic burn injuries. Preclinical models demonstrated a nearly four-fold increase in IL-10, a cytokine supporting tissue repair, and a significant reduction in IL-1B, a key inflammatory driver. This development follows a recent patent issuance for osteopo treatment and a CFO stock purchase, indicating ongoing positive developments and internal confidence. For a micro-cap company facing severe financial challenges, including a going concern warning and Nasdaq delisting risk highlighted in its recent 10-K, this expansion into the estimated $2.55 billion burn care market with promising preclinical data is a material positive development. It validates their core technology and opens a substantial new potential revenue stream, offering a much-needed positive catalyst. Investors should monitor the company's progress towards clinical development in burn patients and any related financing activities.

At the time of this announcement, FBLG was trading at $0.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23M. The 52-week trading range was $0.22 to $1.53. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

FBLG - Latest Insights

FBLG
Oct 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.722 info
Change: -$0.408 (-36%) info
Market Cap: $6.338M info
FBLG
Sep 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.722 info
Change: -$0.708 (-50%) info
Market Cap: $6.338M info
FBLG
Sep 17, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.722 info
Change: -$0.763 (-51%) info
Market Cap: $6.338M info
FBLG
Sep 15, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.722 info
Change: -$0.8259 (-53%) info
Market Cap: $6.338M info
FBLG
Aug 11, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.722 info
Change: -$0.228 (-24%) info
Market Cap: $6.338M info